Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.01 CAD | +1.16% |
|
+0.43% | +6.06% |
Strengths
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 73% by 2026.
- With a P/E ratio at 9.46 for the current year and 8.88 for next year, earnings multiples are highly attractive compared with competitors.
- The company is one of the best yield companies with high dividend expectations.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Ratings chart - Surperformance
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+6.06% | 2.67TCr | - | ||
+4.31% | 7.3TCr | B- | ||
+9.10% | 5.14TCr | B | ||
+7.98% | 5.13TCr | B+ | ||
+23.53% | 4.69TCr | B+ | ||
+14.35% | 4.28TCr | B+ | ||
+18.84% | 3.42TCr | B | ||
-2.82% | 2.85TCr | B | ||
+32.24% | 2.73TCr | A | ||
-16.14% | 2.64TCr | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- GWO Stock
- GWO.PR.N Stock
- Ratings Great-West Lifeco Inc.